Presentation EuroPCR 2012 APPOSITION III: Evaluation of the STENTYS self-apposing bare and drug-eluting stent in 1000 STEMI patients in a real-life setting: in-hospital and 30-day outcomes Presenter: 166648|giovanni amoroso May 18, 2012
News Conference News EuroPCR 2012 Trials Take on Permanent- vs. Biodegradable-Polymer Technology Caitlin E. Cox May 17, 2012
News Conference News EuroPCR 2012 Biolimus-Eluting Stents Perform Well in STEMI, Unselected Populations Jason Kahn May 15, 2012
News Daily News Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting L.A. McKeown April 25, 2012
News Daily News Meta Análisis: Los SLF de 1ª Generación se Muestran Seguros y Eficaces a Largo Plazo contra los STEMI L.A. McKeown April 25, 2012
News Daily News Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES Caitlin E. Cox March 25, 2012
News Daily News Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES Caitlin E. Cox March 25, 2012
News Daily News Stent Thrombosis Risk Lower with Xience vs. First-Generation DES Yael L. Maxwell March 06, 2012
News Daily News El Riesgo de Trombosis del Stent es Menor con Xience que con SLF de 1ª Generación Yael L. Maxwell March 06, 2012
Presentation Comparison of DES with BMS in Patients with STEMI Presenter: B. Kalesan February 27, 2012
News Daily News HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen Leah Lawrence September 29, 2011
News Daily News Model Tries to Simplify Choice Between Drug-Eluting, Bare-Metal Stents L.A. McKeown September 16, 2011
News Conference News Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS September 02, 2011
News Daily News TRIAS HR Published: Genous Stent Doubles Target Lesion Failure Leah Lawrence August 23, 2011
News Daily News HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years Jason Kahn June 13, 2011